ID
33251
Descrição
Study ID: 107434 Clinical Study ID: NAP107434 Study Title: A randomised, double-blind, double-dummy, placebo controlled, three-way cross-over study to investigate the effect of single oral doses of 100 mg GW273225 (4030W92) and 325 mg LAMICTAL on resting motor threshold in healthy subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Study Link: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GW273225 Trade Name: lamictal Study Indication: Bipolar Disorder This form contains informations about additional clinical laboratory safety tests. It should be filled out at each visit if any unscheduled laboratory safety tests have been performed. Screening Visit: 28 days prior to first dosing. Treatment Period: The day before dosing, until 48h after dosing. Follow-Up: 14-21 days after last dose
Palavras-chave
Versões (2)
- 03/12/2018 03/12/2018 -
- 21/01/2019 21/01/2019 -
Titular dos direitos
GlaxoSmithKline
Transferido a
3 de dezembro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Effect of Lamictal on Resting Motor Threshold
Clinical Laboratory Safety Tests 2
- StudyEvent: ODM
Similar models
Clinical Laboratory Safety Tests 2
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C1552089 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0038586 (UMLS CUI [1,2])
C1552089 (UMLS CUI [1,2])
C0947611 (UMLS CUI [1,2])
C1552089 (UMLS CUI [1,2])